| Literature DB >> 23635712 |
Lars Barquist1, Christine J Boinett, Amy K Cain.
Abstract
In this review, we discuss transposon-insertion sequencing, variously known in the literature as TraDIS, Tn-seq, INSeq, and HITS. By monitoring a large library of single transposon-insertion mutants with high-throughput sequencing, these methods can rapidly identify genomic regions that contribute to organismal fitness under any condition assayable in the laboratory with exquisite resolution. We discuss the various protocols that have been developed and methods for analysis. We provide an overview of studies that have examined the reproducibility and accuracy of these methods, as well as studies showing the advantages offered by the high resolution and dynamic range of high-throughput sequencing over previous methods. We review a number of applications in the literature, from predicting genes essential for in vitro growth to directly assaying requirements for survival under infective conditions in vivo. We also highlight recent progress in assaying non-coding regions of the genome in addition to known coding sequences, including the combining of RNA-seq with high-throughput transposon mutagenesis.Entities:
Keywords: bacteria; essential genes; sRNA; sequencing; systems biology; transposon mutagenesis
Mesh:
Substances:
Year: 2013 PMID: 23635712 PMCID: PMC3849164 DOI: 10.4161/rna.24765
Source DB: PubMed Journal: RNA Biol ISSN: 1547-6286 Impact factor: 4.652

Figure 1. An illustration of the workflow typical of transposon-insertion sequencing protocols. Transposons are represented by pink lines, sequencing adaptors by blue, genomic DNA by black and PCR primers by green. Mutants are generated through either in vivo or in vitro transposition and subsequent selection for antibiotic resistance. These mutants are pooled, and optionally competed in test conditions, then genomic DNA is extracted and fragmented by restriction digest or physical shearing. Sequencing adaptors are ligated, some protocols then perform a step to purify fragments containing transposon insertions, and PCR with transposon- and adaptor-specific primers is used to specifically enrich for transposon-containing fragments. The fragments are then sequenced and mapped back to a reference genome to uniquely identify insertion sites with nucleotide-resolution. Dashed boxes indicate steps which differ between protocols.
Table 1. Applications of transposon-insertion sequencing
| Study | Publication date | Organism | Total mutants | Unique insertion sites; Density | Application | Tn used | Name coined |
|---|---|---|---|---|---|---|---|
| Hutchison III et al., Science | Oct 1999 | 1,291 | 685; ~1/850 bp | Required gene sets | Tn | Global Transposon Mutagenesis | |
| Goodman et al., Cell Host and Microbe | Sep 2009 | 2 × 35,000 | 35,000;1/182 bp | Establishment in human gut as a natural habitat | Mariner | INSeq | |
| Gawronski et al., PNAS | Sep 2009 | 75,000 | 55,935; 1/32 bp | Prolonged survival in lung in vivo | Mariner | HITS | |
| van Opijnen et al., Nature Methods | Oct 2009 | 6 × 25,000 | 23,875; 1/91bp | Transcriptional regulation and carbohydrate transport | Mariner | Tn-seq | |
| Langridge et al., Genome Research | Dec 2009 | 1.1 million | 370,000; | Gene requirements, bile tolerance | Tn | TraDIS | |
| Gallagher et al., mBio | Jan 2011 | ~100,000 | 95,905; 1/65 bp | Tobramycin resistance | Mariner | Tn-seq (circle method) | |
| Eckert et al., J Bact. | Jan 2011 | 19 × 95 | 1,645 | Colonization of bovine intestinal tract; retrospective re-evaluation of a STM study | Tn | - | |
| Christen et al., Mol Syst Biol. | July 2011 | 800,000 | 428,735; 1/8 bp | Gene/ncRNAs/promoter requirements | Tn | - | |
| Griffin et al., PLOS Pathogens | Sept 2011 | 2 × 100,000 | 36,488;1/120 bp | Gene requirements and cholesterol utilization | Mariner | - | |
| Khatiwara et al., AEM | May 2012 | 16,000 | ~8,000; ~1/610 | Bile, low nutrient and heat tolerance | Tn | - | |
| Mann et al., PLOS Pathogens | July 2012 | ~9,000–24,000 | ~8,000‒22,000 | Determining roles of sRNAs in pathogenesis | Mariner | - | |
| van Opijnen and Camilli, Genome Research | July 2012 | ~4,000‒30,000 | Varying | Stress response and metabolism in vitro and murine in vivo colonization | Mariner | - | |
| Brutinel and Gralnick, Molecular Microbiology | Aug 2012 | 50,000 | 26,793; ~1/191 bp | Gene requirements and Metabolism | Mariner | - | |
| Zhang et al., PLOS Pathogens | Sept 2012 | 2 × 100,000 | 36,488; ~1/120 bp | Identifying genes, regulators and ncRNAs required for growth | Mariner | - | |
| Klein et al., BMC Genomics | Oct. 2012 | N/A | 54,000; 1/43 bp | Gene requirements | Mariner | - | |
| Pickard et al., J Bact | Jan 2013 | 1.1 million | 370,000; 1/13 bp | Bacteriophage infection | Tn | - | |
| Barquist et al., Nuc. Acids Res | March 2013 | 1.1 million | 370,000; 1/13 bp | Comparison of coding and non-coding gene requirements between two | Tn | - |
1 The same mutant library was used in these studies. A collection of studies to date utilizing transposon-insertion sequencing. Columns: (1) study reference, (2) date of publication, (3) organism mutagenized, (4) number of mutants generated, (5) number of unique insertion sites recovered from sequencing, (6) brief description of the application, (7) transposon used, (8) method name coined, if any.

Figure 2. Applications of transposon-insertion sequencing to non-coding RNAs. (A) Plots of genomic regions in Mycobacterium tuberculosis containing the required non-coding RNAs RNase P (top) and tmRNA (bottom). Tracks, from top to bottom, 1. Histogram of insertion counts, 2. Comprehensive heat-map of requirement of 500-bp windows, 3. Position of annotated genes, 4. Position of TA dinucleotide sites, 5. Position of non-coding RNA. Reproduced from reference 23. (B) 1 × 1 competition assays validate attenuating Streptococcus pneumoniae sRNA mutants identified by transposon-insertion sequencing. Mice were infected with defined deletions of sRNAs identified as attenuating by Tn-seq and wild-type S. pneumoniae TIGR4 at the body site indicated and bacterial densities were compared 24 h post-infection. These plots show the derived competitive index in blood (top) and the nasopharnyx (bottom). Each point represents the result of a competition experiment between an sRNA deletion mutant and wild-type TIGR4. A competitive index of 1 indicates equivalent numbers of mutants and wild-type were recovered. Modified from reference 46.
Table 2. Advantages and limitations of transposon-insertion sequencing
| Advantages | Limitations |
|---|---|
| Library construction is extremely rapid in comparison to targeted deletion libraries. | Requirements for particular nucleotides at transposon-insertion sites or insertion biases can limit resolution. |
| Gene requirements and fitness effects can be quickly assayed in a wide range of conditions. | Determination of gene essentiality is dependent on insertion density, and is less conclusive than targeted gene deletion in clonal populations. |
| The precise location of transposon insertions can be determined due to the nucleotide resolution of high-throughput sequencing. | Only genomic regions that tolerate insertions under the conditions of library creation may be assayed for fitness effects in further conditions. |
| Wide dynamic range compared with older microarray-based technologies. | The dynamic range for fitness effects is dependent on mutant abundance in the initial library and may be limiting for some genes. |
| Requirements and fitness effects of genomic regions can be determined independently of annotation. | Mutants must be reconstructed for follow-up experiments in the absence of specialized protocols and robotics (see e.g., Goodman, 2009 |